Scarica l'app Stockscreener
0.6681
4.20%
-0.0293
Pre-mercato:
.70
0.0319
+4.77%
Precedente Chiudi:
$0.6974
Aprire:
$0.6974
Volume 24 ore:
307.18K
Relative Volume:
0.87
Capitalizzazione di mercato:
$27.92M
Reddito:
-
Utile/perdita netta:
$-74.56M
Rapporto P/E:
-0.3648
EPS:
-1.8316
Flusso di cassa netto:
$-60.27M
1 W Prestazione:
+6.91%
1M Prestazione:
+18.27%
6M Prestazione:
+110.76%
1 anno Prestazione:
-33.85%
Intervallo 1D:
$0.6451
$0.708
Intervallo di 1 settimana:
$0.60
$0.72
Portata 52W:
$0.2201
$1.2401
Rallybio Corp Stock (RLYB) Company Profile
Nome
Rallybio Corp
Settore
Industria
Telefono
203- 859-3820
Indirizzo
234 CHURCH STREET, NEW HAVEN
Confronta RLYB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RLYB
Rallybio Corp
|
0.6681 | 29.14M | 0 | -74.56M | -60.27M | -1.8316 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Rallybio Corp Stock (RLYB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-09 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-05-15 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-02-07 | Downgrade | Jefferies | Buy → Hold |
| 2023-04-17 | Iniziato | H.C. Wainwright | Buy |
| 2023-04-10 | Iniziato | Wedbush | Outperform |
| 2022-12-09 | Iniziato | JP Morgan | Overweight |
| 2022-02-22 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-08-23 | Iniziato | Cowen | Outperform |
| 2021-08-23 | Iniziato | Evercore ISI | Outperform |
| 2021-08-23 | Iniziato | Jefferies | Buy |
Mostra tutto
Rallybio Corp Borsa (RLYB) Ultime notizie
How to monitor Rallybio Corporation with trend dashboardsJuly 2025 Momentum & Low Risk High Reward Trade Ideas - newser.com
Why retail investors favor Rallybio Corporation stockJuly 2025 Patterns & Reliable Momentum Entry Alerts - newser.com
Is Rallybio Corporation trending in predictive chart modelsQuarterly Market Summary & Daily Stock Trend Watchlist - newser.com
How Rallybio Corporation stock performs in rising dollar environmentJuly 2025 Fed Impact & Community Verified Trade Signals - newser.com
Why Rallybio Corporation stock remains on buy listsBull Run & Verified Trade Idea Suggestions - newser.com
Will Rallybio Corporation continue its uptrendShort Setup & Accurate Entry/Exit Alerts - newser.com
Technical signs of recovery in Rallybio CorporationJuly 2025 Price Swings & Verified Momentum Stock Watchlist - newser.com
How to build a custom watchlist for Rallybio CorporationMarket Trend Report & Weekly Stock Breakout Alerts - newser.com
Will Rallybio Corporation stock beat EPS estimatesGap Up & Stepwise Entry and Exit Trade Signals - newser.com
Can Rallybio Corporation stock hit record highs againJuly 2025 Pullbacks & Verified Momentum Stock Watchlist - newser.com
Is Rallybio Corporation stock reversal real or fakeWall Street Watch & Capital Efficient Trade Techniques - newser.com
Is Rallybio Corporation a candidate for recovery playJuly 2025 News Drivers & Accurate Entry and Exit Point Alerts - newser.com
Using Ichimoku Cloud for Rallybio Corporation technicalsMarket Activity Recap & Precise Entry and Exit Recommendations - newser.com
Rallybio’s RLYB116 Study: A Potential Game-Changer in Hematologic and Autoimmune Disease Treatment - TipRanks
Is Rallybio Corporation stock undervalued vs historical averagesMarket Performance Recap & Fast Entry and Exit Trade Plans - Fundação Cultural do Pará
Why Rallybio Corporation stock attracts global investors2025 Year in Review & Stepwise Entry and Exit Trade Signals - fcp.pa.gov.br
Rallybio Corp Azioni (RLYB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.64%
0.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):